An Open Label Study of ANX005 in Subjects With, or at Risk for, Manifest Huntington's Disease

Clinical trial NCT04514367 · COMPLETED

Trial details

NCT number: NCT04514367
Sponsor: Annexon, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Huntington Disease

Start date: 2020-08-17
Primary completion: 2022-01-28
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.